SCIENTIFIC & MEDICAL COMMUNICATION▪ Scientific narrative & messaging▪ Posters▪ Oral presentations▪ Pre-recorded virtual presentations▪ Publications & presentation planning ▪ Review processesCORPORATE COMMUNICATION▪ Key messages ▪ Press releases▪ Slide decks▪ Annual report contents re: science & programsMEDIA RELATIONS▪ Company factsheet▪ Science & technology factsheetsDIGITAL COMMUNICATION▪ Social media strategy▪ Web contents re: science & technologyCLINICAL TRIALS▪ Patient website contents▪ Patient brochuresSCIENTIFIC ILLUSTRATIONS & VIDEOS▪ Scientific visualization strategy ▪ Branded science visual library▪ Explanatory cartoons▪ Corporate videosINTERNAL COMMUNICATION▪ Key messages▪ Internal emails

ROLE• Support investor and media relations function for all things scientific, e.g. copy, visuals, slides, answers to scientific questions from investors or reporters• Create science visuals to support corporate communication across channels, e.g. investor and media relations, social media, patient advocacy• Lead global publication planning• Support scientists to implement publication strategy and deliver high-quality publications• Develop patient materials to strengthen clinical trial recruitment and retention• Lead European internal communications to facilitate global integration of European units into company’s cultureMAIN ACHIEVEMENTS• Led creation of science illustrations and animations library supporting large range of business units• Helped scientists create over 30 high-quality posters for leading conferences• Launched multi-country and multilingual clinical study websites for two clinical studies, STAAR (gene therapy for Fabry disease) and STEADFAST (cell therapy for renal transplantation)• Created tutorial videos to teach clinical study nurses how to prepare products for patient infusion• Revised publication planning processes and created global planning tracker tool using Airtable• Organized and led European internal events, including Town Halls and Scientific seminars

ROLE• Lead all communication activities of a French cellular therapy company listed on the French stock market, including press releases, analyst and investor conference calls, corporate presentation, stock exchange filings, social networks and website.• Develop key messages and communication plan, working closely with CEO & leadership team• Spokesperson in European IR eventsMAIN ACHIEVEMENTS• Managed communications around strategic reorganization, financing rounds, academic partnerships, preclinical result presentations, contract manufacturing organization (CMO) appointments, IP updates• Designed and launched new website• Created animated explainer video, company presentation videos and scientific illustrations• Developed company’s presence on social networks (Twitter, LinkedIn)• Implemented internal contacts database and IR database

ROLE• Lead all communication activities of a France-based pharmaceutical company focused on ophthalmology and listed on the French stock market, including press releases, analyst and investor conference calls, corporate presentation, stock exchange filings (Document de Référence) and websites.• Work closely with senior management, notably the CEO, in developing key messages and communication plan.• Manage external consultants, including PR agencies, communication and media relations consultants and web designers.• Spokesperson for French investors.• Media relations in France.MAIN ACHIEVEMENTS• Manage communications around the following events: - Acquisition of Aciex Therapeutics, a private US company (including successful Extraordinary General Meeting with shareholder approval) - Acquisitions of Eupharmed, a private Italian company and Doliage, a private French company - Divestment of US diagnostics subsidiary Nicox Inc. (acquired by Valeant) - In-licensing and out-licensing agreements with major partners, such as Bausch + Lomb - Launch of several commercial products in the United States and in Europe - Financial results, Board and leadership team changes• Lead complete rebranding in 2012 with external agency (new logo, new website, new templates)• Launch and manage 6 new websites dedicated to the Group’s commercial operations in the United States, United Kingdom, Italy, Spain, France and Germany (2014-2015)• Implement internal newsletter with Human Resources departement

ROLE• Growing role, from supporting the Director of Corporate Communications and Investor Relations to taking overall responsibility for the preparation of press releases and other communications materials in English and French and coordinating the internal and external review processMAIN ACHIEVEMENTS• Very actively involved in a €70 million rights issue (November 2009): Document de Référence, International Offering Memorandum, dedicated website portal, road show presentation and press releases, in collaboration with lawyers, bankers and consultants.• Took full responsibility for the following projects following the departure of the Communications Director : - FDA Advisory Committee for naproxcinod (May 2010): extensive question and answer document addressing potential questions from media and analysts, related to the content of briefing documents and other topics likely to be raised during the meeting (in collaboration with R&D department and external consultants). - FDA PDUFA date for naproxcinod (July 2010): preparation of draft press releases based on all possible scenarios ahead of FDA’s answer.

PhD in medicinal chemistry: Design and synthesis of non-peptidic inhibitors of Grb2-SH2- De novo design, molecular modelling- Multi-step synthesis, analytical chemistry- Investigation of the activity of the synthesized molecules on the targeted protein